Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An announcement from Creo Medical ( (GB:CREO) ) is now available.
Creo Medical Group announced it will release its audited financial results for the year ending December 31, 2024, on May 19, 2025. This announcement is significant as it could provide insights into the company’s financial health and its strategic positioning within the medical device industry, potentially impacting stakeholders’ perceptions and future investments.
More about Creo Medical
Creo Medical Group plc is a medical device company specializing in minimally invasive electrosurgical devices aimed at enhancing endoscopic procedures for pre-cancer and cancer patients. The company focuses on improving patient outcomes through its CROMA technology, powered by Kamaptive, which integrates multi-modal energy sources for precise surgical interventions.
YTD Price Performance: -49.49%
Average Trading Volume: 975,884
Technical Sentiment Signal: Buy
Current Market Cap: £40.63M
Find detailed analytics on CREO stock on TipRanks’ Stock Analysis page.